This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Uttam Kumar Ray: Innovator in Pharmaceutical Chemistry
Introduction
Uttam Kumar Ray is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of cefuroxime axetil. His innovative approach has led to advancements in the quality and availability of this important medication.
Latest Patents
Uttam Kumar Ray holds a patent for a process titled "Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil." This patent describes a method for preparing a pure amorphous form of cefuroxime axetil by dissolving crystalline cefuroxime axetil in acetic acid, which includes at least 5% v/v water. The process involves recovering the amorphous form from the solution by adding additional water, ensuring that the volume is sufficient to precipitate the desired product. This innovative method enhances the purity and effectiveness of cefuroxime axetil.
Career Highlights
Uttam Kumar Ray is associated with Ranbaxy Laboratories, Inc., where he has contributed to various research and development projects. His work has been instrumental in improving pharmaceutical formulations and processes. With a focus on innovation, he has dedicated his career to enhancing drug quality and efficacy.
Collaborations
Uttam Kumar Ray has collaborated with notable colleagues, including Vijay Kumar Handa and Om Dutt Tyagi. These collaborations have fostered a productive environment for research and innovation within the pharmaceutical industry.
Conclusion
Uttam Kumar Ray's contributions to pharmaceutical chemistry, particularly through his patent on cefuroxime axetil, highlight his role as an innovator in the field. His work continues to impact the quality of medications available to patients, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
